肿瘤相关静脉血栓栓塞风险评估模型的研究进展
Research Progress of Risk Assessment Models for Cancer-associated Venous Thromboembolism
陈思宇 1但敏 1姜永生1
作者信息
- 1. 华中科技大学同济医学院附属同济医院肿瘤科,武汉 430030
- 折叠
摘要
恶性肿瘤是静脉血栓栓塞的重要危险因素,肿瘤患者发生静脉血栓栓塞的风险是非肿瘤患者的4～7倍.静脉血栓栓塞成为肿瘤患者除肿瘤进展或复发之外的首要死亡原因.静脉血栓栓塞的出现会导致抗肿瘤治疗的中断、延迟以及死亡率的增加.目前,国内外指南推荐对肿瘤患者进行静脉血栓栓塞风险评估.该文对目前肿瘤相关静脉血栓栓塞风险评估方法进行综述.
Abstract
Cancer is a key risk factor for venous thromboembolic events.The risk of VTE in tumor patients is 4 to 7 times that of non-tumor patients,which is the second cause of death after tumor progression or recurrence in cancer patients.Cancer associated thromboembolism results in delays or discontinuation of anti-cancer treatment and increased mortality.At present,clinical practice guidelines at home and abroad recommend risk assessment of venous thromboembolic events for cancer pa-tients.In this review,the risk assessment models were summarize for cancer-associated venous thromboembolism.
关键词
肿瘤/静脉血栓栓塞/风险预测Key words
cancer/venous thromboembolism/risk assessment引用本文复制引用
基金项目
湖北陈孝平科技发展基金会资助项目(CXPJJH122006-1026)
出版年
2024
NETL
NSTL
万方数据